BioWednesday Webinar: ESG and Life Science Investment

Online registration is closed but if you would like to attend please contact alicia@onenucleus.com

Environmental, Social and Governance (ESG) factors are receiving increasing attention in business as business leaders, their investors and their staff seek to align their personal and company values with those of all their stakeholders. Life Sciences has the potential to score extremely well on societal aspects due to the impact of innovative treatments to improve lives, widen access to new medicines and address unmet needs. Other elements such as sustainability and the drive to ‘net zero’, diversity and governance present the same challenge to this sector as any other perhaps. Whether these challenges are felt the same between public and private companies, investors and all parts of the Life Sciences field and how should all companies be responding will be the focus of this BioWednesday discussion.

Panel:
Hollie Vile, Director, Optimum Strategic Communications (Moderator)
Paul Major, Portfolio Manager, Bellevue Asset Management
Claire Thompson, CEO, Agility Life Sciences
Lindsey Stewart, Senior Investor Engagement Manager, KPMG
Jason Snape, Global Head of Environment, AstraZeneca
Alice Lin Pomponio, Manager Director, BrightEdge at American Cancer Society

Prices
One Nucleus Members: Free
Non-Members: £50 +VAT
Academics: please contact Alicia